SUNNOVA ENERGY INTERNATIONAL (NOVA)

US86745K1043 - Common Stock

3.75  -0.28 (-6.95%)

After market: 3.79 +0.04 (+1.07%)

Fundamental Rating

1

Taking everything into account, NOVA scores 1 out of 10 in our fundamental rating. NOVA was compared to 22 industry peers in the Independent Power and Renewable Electricity Producers industry. NOVA has a bad profitability rating. Also its financial health evaluation is rather negative. NOVA is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NOVA had negative earnings in the past year.
NOVA had a negative operating cash flow in the past year.
In the past 5 years NOVA always reported negative net income.
In the past 5 years NOVA always reported negative operating cash flow.

1.2 Ratios

NOVA has a Return On Assets of -3.21%. This is in the lower half of the industry: NOVA underperforms 77.27% of its industry peers.
NOVA has a Return On Equity of -23.23%. This is amonst the worse of the industry: NOVA underperforms 81.82% of its industry peers.
Industry RankSector Rank
ROA -3.21%
ROE -23.23%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-4.39%
ROE(3y)-17.23%
ROE(5y)-20.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of NOVA (42.86%) is worse than 63.64% of its industry peers.
In the last couple of years the Gross Margin of NOVA has declined.
NOVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-8.9%

0

2. Health

2.1 Basic Checks

NOVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOVA has more shares outstanding than it did 1 year ago.
NOVA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NOVA is higher compared to a year ago.

2.2 Solvency

NOVA has an Altman-Z score of 0.01. This is a bad value and indicates that NOVA is not financially healthy and even has some risk of bankruptcy.
NOVA has a worse Altman-Z score (0.01) than 63.64% of its industry peers.
A Debt/Equity ratio of 4.45 is on the high side and indicates that NOVA has dependencies on debt financing.
NOVA's Debt to Equity ratio of 4.45 is on the low side compared to the rest of the industry. NOVA is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACC4.32%

2.3 Liquidity

NOVA has a Current Ratio of 0.86. This is a bad value and indicates that NOVA is not financially healthy enough and could expect problems in meeting its short term obligations.
NOVA's Current ratio of 0.86 is on the low side compared to the rest of the industry. NOVA is outperformed by 63.64% of its industry peers.
A Quick Ratio of 0.73 indicates that NOVA may have some problems paying its short term obligations.
The Quick ratio of NOVA (0.73) is worse than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.73

6

3. Growth

3.1 Past

The earnings per share for NOVA have decreased strongly by -42.33% in the last year.
The Revenue has grown by 12.17% in the past year. This is quite good.
NOVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 47.17% yearly.
EPS 1Y (TTM)-42.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-84.91%
Revenue 1Y (TTM)12.17%
Revenue growth 3Y64.87%
Revenue growth 5Y47.17%
Sales Q2Q%18.6%

3.2 Future

Based on estimates for the next years, NOVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.56% on average per year.
The Revenue is expected to grow by 20.18% on average over the next years. This is a very strong growth
EPS Next Y25.51%
EPS Next 2Y16.63%
EPS Next 3Y5.9%
EPS Next 5Y8.56%
Revenue Next Year12.6%
Revenue Next 2Y17.91%
Revenue Next 3Y18.04%
Revenue Next 5Y20.18%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.63%
EPS Next 3Y5.9%

0

5. Dividend

5.1 Amount

No dividends for NOVA!.
Industry RankSector Rank
Dividend Yield N/A

SUNNOVA ENERGY INTERNATIONAL

NYSE:NOVA (11/15/2024, 8:04:01 PM)

After market: 3.79 +0.04 (+1.07%)

3.75

-0.28 (-6.95%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap468.56M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.21%
ROE -23.23%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 42.86%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.86
Quick Ratio 0.73
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-42.33%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y25.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.17%
Revenue growth 3Y64.87%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y